K SEC filing received on January 31, 2025, that the company has been notified by The Nasdaq Stock Market, LLC about its failure to meet the minimum bid requirement for continued listing on the Nasdaq ...

Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Hotel101 Global—a unit of DoubleDragon, which is jointly owned by Philippine fast food giant Jollibee founder Tony Tan ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine ...

DoubleDragon Corp., the property venture of tycoons Edgar “Injap” Sia and Tony Tan Caktiong, has moved a step closer toward ...

DoubleDragon Corp., the property venture of tycoons Edgar Sia II and Tony Tan Caktiong, has moved a step closer toward ...

Universe Pharmaceuticals (UPC) announced that the company received a letter from the Nasdaq Stock Market on January 29 notifying the company ...

The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Zentalis, or following a bona fide period of non-employment, as an ...

Global Star Acquisition Inc., a special purpose acquisition company with a market capitalization of $44.27 million, is confronting delisting from the Nasdaq Stock Market after failing to meet the ...

The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...

DOUBLEDRAGON Corp.’s (DD) subsidiary, Hotel101 Global Pte. Ltd., is nearing its $2.3-billion (P130 billion) listing on the Nasdaq Stock Exchange in the United States after meeting all requirements.